bgv tech.eu

Dutch VC BioGeneration Ventures closes €105 million fund for early-stage biotech startups in Europe

BioGeneration Ventures (BGV), an early-stage VC in European biotech, has closed its fourth fund at €105 million, bringing the Dutch firm’s total assets under management above €220 million. Investors in BGV IV include Bristol Myers Squibb, Schroder Adveq, the European Investment Fund, Industriens Pension and KfW Capital.  The Naarden-based VC aims to build new companies […]

biostrand tech.eu

Belgian startup BioStrand raises €2 million to disrupt genetic data analysis

Belgian company BioStrand has raised €2 million to continue developing its genetic data analysis technology, which has been lauded for its precision and potential applications in medicine, biotechnology and agriculture. The investment comes from K&E, the investment fund of Koen Quaghebeur and Els Paesmans, who founded the crop protection company Globachem. The BioStrand methodology identifies […]

Uromems tech.eu

French medtech company UroMems raises €16 million Series B

UroMems, French developer of medical devices that help with urinary incontinence, has secured €16 million in a Series B round, a combination of equity and debt, led by Hil-Invent with co-investor Financière Arbevel. The Grenoble-based company has created an electronic artificial urinary sphincter (eAUS), an implantable medical device that treats Stress Urinary Incontinence (SUI). “SUI […]

lifebit tech.eu

London-based Lifebit Biotech clinches $7.5 million Series A for genomic data analytics platform

Lifebit Biotech, a London-based big data processor for medical research, has raised $7.5 million (£6 million) in Series A funding to fuel ongoing product development and international expansion. The round was led by Idinvest Partners, with participation from previous investors Pentech Ventures, Beacon Capital and Connect Ventures. In a press release, the company cited that […]

Biotech Barometer: European-listed biotech companies are showing positive signals despite uneven performances in H2’2019

Editor’s note: This is a sponsored article, which means it is independently written by our editorial team but financially supported by another organisation, in this case, Euronext. If you would like to learn more about sponsored posts on Tech.eu, read this and contact us if you are interested in partnering with us. Euronext and BiotechBourse […]

Seekyo tech.eu

French biotech Seekyo raises €800,000 to test its tumor-targeting smart chemotherapy

Seekyo, a Poitiers-based biotech startup developing new chemotherapies, has raised €800,000 in seed funding to validate its flagship tumor-targeting drug. The financing consists of €400,000 from angel investors in the BAdGE, Investessor, and Synergence networks; a €150,000 loan from the European Investment Fund (EIF) Investment Initiation; and €250,000 in convertible bonds from the French Tech […]

Aqemia tech.eu

Aqemia raises €1 million pre-seed round to disrupt drug discovery market

Aqemia, a Parisian deep tech startup, has raised €1 million pre-seed round from Elaia to develop its molecule matching technology. The company aims to transform pharmaceutical research and disrupt the $60 billion drug discovery market. Aqemia’s core software, developed from academic research at École normale supérieure (PSL), can predict the effectiveness of a pharmaceutical drug. […]